Meet your 2022 Faculty for the Master Class On Demand Learning

Harold J. Burstein MD, PhD

Medical Oncologist
Dana-Farber Cancer Institute

Professor of Medicine
Harvard Medical School

Jean M. Connors MD

Medical Director, Anticoagulation Management Service
Brigham and Women’s Hospital
Dana-Farber Cancer Institute

Associate Professor of Medicine
Harvard Medical School

Bruce E. Johnson MD

Chief Clinical Research Officer
Dana-Farber Cancer Institute

Professor of Medicine
Harvard Medical School

Janet L. Abrahm, MD

Medical Oncologist
Dana-Farber Cancer Institute

Professor of Medicine
Harvard Medical School

Thomas A. Abrams, MD

Senior Physician
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School

Kenneth C. Anderson, MD

Program Director
Jerome Lipper Multiple Myeloma Center and LeBow Institute
for Myeloma Therapeutics
Dana-Farber Cancer Institute

Kraft Family Professor of Medicine
Harvard Medical School

Sharon L. Bober, PhD

Senior Psychologist
Dana-Farber Cancer Institute
Assistant Professor of Psychiatry
Harvard Medical School

Jennifer A. Chan, MD, MPH

Clinical Director, Gastrointestinal Cancer Center
Director, Program in Carcinoid and Neuroendocrine Tumors
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School

Matthew S. Davids MD, MMSC

Director
Center for Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute

Assistant Professor of Medicine
Harvard Medical School

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute

Professor of Medicine
Harvard Medical School

George D. Demetri, MD

Director, Sarcoma Center
Senior Vice President for Experimental Therapeutics
Quick Family Chair in Medical Oncology
Dana-Farber Cancer Institute

Professor of Medicine
Harvard Medical School

Robert Dreicer, MD

Professor of Medicine and Urology
University of Virginia School of Medicine

Associate Director for Clinical Research and the Deputy Director
University of Virginia Cancer Center

Section Head of Medical Oncology and Co-Director
Paul Mellon Urologic Institute.

Peter C. Enzinger, MD

Director, Center for Esophageal and Gastric Cancer
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School

Robert I. Haddad, MD

McGraw Chair in Head and Neck in Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School

F. Stephen Hodi, MD

Director, Melanoma Center
Director, Center for Immuno-Oncology
Sharon Crowley Martin Chari in Melanoma
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School

Ann S. LaCasce MD, MMSC

Director, Fellowship Program (Hematology-Medical Oncology)
Dana-Farber/Massachusetts General Brigham
Associate Professor of Medicine
Harvard Medical School

Nancy U. Lin MD

Associate Chief, Division of Breast Oncology, Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute

Associate Professor of Medicine
Harvard Medical School

Joyce F. Liu, MD, MPH

Associate Chief, Division of Gynecologic Oncology
Director of Clinical Research, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School

Ursula A. Matulonis, MD

Chief, Division of Gynecologic Oncology
Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School

Mary Ellen Taplin, MD

Chair, Executive Committee for Clinical Research
Chair of Clinical Research, Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School

Ayalew Tefferi, MD

Professor of Medicine and Hematology
Mayo Medical School

Alexis A. Thompson MD, MPH

Chief, Division of Hematology
Elias Schwartz MD Endowed Chair in Hematology
Children’s Hospital of Philadelphia

Matthew B. Yurgelun, MD

Director, Lynch Syndrome Center
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School